IFO50432 KP-N-RT-BM-1
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | IFO50432 | Cell Name | KP-N-RT-BM-1 |
---|---|---|---|
Profile | neuroblastoma, from bone marrow, neuronal and Schwannian differentiation | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | Age | ||
Identity | available | Tissue for Primary Cancer | neural |
Case history | neuroblastoma | Metastasis | Yes |
Tissue Metastasized | bone marrow | Genetics | |
Life Span | infinite | Crisis PDL | |
Morphology | neuroblast-like | Character | neuroblastoma, from bone marrow, neuronal and Schwannian differentiation |
Classify | tumor | Established by | Sugimoto, T. et al. |
Registered by | Sugimoto,T. | Regulation for Distribution | |
Comment | Year | 1994 | |
Medium | RPMI1640 medium with 10% fetal bovine serum | Methods for Passages | trypsin-EDTA |
Cell Number on Passage | Race | ||
CO2 Conc. | 5 % | Tissue Sampling | neuroblastoma |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:2833349 | Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine. Sugimoto T,Kato T,Sawada T,Horii Y,Kemshead JT,Hino T,Morioka H,Hosoi H Cancer Res. 1988 May 1;48(9):2531-7 |
Pubmed id:2820569 | Morphological differentiation of human neuroblastoma cell lines by a new synthetic polyprenoic acid (E5166). Sugimoto T,Sawada T,Matsumura T,Horii Y,Kemshead JT,Suzuki Y,Okada M,Tagaya O,Hino T Cancer Res. 1987 Oct 15;47(20):5433-8 |
Pubmed id:3731124 | Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient. Sugimoto T,Sawada T,Matsumura T,Kemshead JT,Ishii T,Horii Y,Morioka H,Morita M,Reynolds CP Cancer Res. 1986 Sep;46(9):4765-9 |
Images |
---|
LOT Information
Cell No. | IFO50432 | Cell Name | KP-N-RT-BM-1 |
---|---|---|---|
LOT No. | 1119 | Lot Specification | distribution |
Medium | RPMI 1640, 90% ; FBS, 10% | Temperature | 37 C |
Cell Density at Seeding | 10^5 cells/ml | Methods for Passages | trypsin-EDAT |
Doubling Time | Cell Number in Vial (cells/1ml) | 1.2 x 10^6 | |
Viability at cell freezing (%) | 87 | Antibiotics Used | free |
Passage Number | P77 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | G6PD (type B), MD, AST |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | 10% DMSO, 20% serum (final conc.)-culture medium | CO2 Conc. | |
Viability immediately after thawing (%) | Additional information |
Cell No. | IFO50432 | Cell Name | KP-N-RT-BM-1 |
---|---|---|---|
LOT No. | 01212014 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; GIBCO Cat. # 10091) | Temperature | 37 C |
Cell Density at Seeding | 0.8 -1.4 x 10^5 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | Cell Number in Vial (cells/1ml) | 1.8 x 10^6 | |
Viability at cell freezing (%) | 88.5 | Antibiotics Used | free |
Passage Number | P78 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 88.5 | Additional information |